CPT code 43648 covers laparoscopic testing, adjustment, or removal of previously implanted gastric neurostimulator electrodes when they are not functioning as required. The procedure is clinically important because gastric neurostimulation is a treatment option for gastroparesis, a condition that can cause severe gastric emptying delays and is frequently seen as a complication of diabetes mellitus. Nationally, this code represents a specialized surgical device management service tied to durable implantable systems and perioperative care pathways.

Key payers in the coverage and reimbursement landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the service, expected sites of care (hospital inpatient, outpatient surgical centers), and the typical operative nature of the encounter. The analysis also outlines common modifiers associated with device and operative reporting and notes gaps where input data were not provided.

This publication helps billing, coding, and policy professionals understand what CPT code 43648 represents, why it matters for device management and gastroparesis care nationally, and what elements to expect in claims and coverage discussions. Data not available in the input are identified explicitly where relevant.